Recent research suggests that a new approach could help even patients with advanced forms of fatty liver disease.

These scores are defined as follows; stages of fibrosis (F) (Fig. 1): F0, no fibrosis; F1, portal fibrosis without septa; F2, portal fibrosis with rare septa, F3, numerous septa without cirrhosis ...

The Enhanced Liver Fibrosis (ELF) test consists of an algorithm of three fibrosis markers (hyaluronic acid, amino-terminal propeptide-of-type-III-collagen, tissue-inhibitor of matrix ...

Discover how integrating advanced imaging, digital pathology, and molecular analysis, can refine fibrosis staging and ...

Did you see this? Nearly 1 in 10 Americans have asthma. Here's what causes it.

Devonian Health Group Inc. (“Devonian” or the “Company”) (TSXV: GSD; OTCQB: DVHGF), a clinical stage corporation focused on developing unique solution ...

Akero Therapeutics reports a 39% improvement in cirrhosis patients using EFX. See why AKRO stock is soaring with the breakthrough Phase 2b SYMMETRY data.

or metabolic-associated steatohepatitis liver disease (MASLD) patients. The SYNCHRONY Real-World study is notable for its comprehensive inclusion of patients across fibrosis stages F1-F4.